Variation in adherence to medications across the healthcare system in two comparative effectiveness research cohorts

To assess heterogeneity in adherence to medications in two example comparative effectiveness research studies. We analyzed data from commercially insured patients initiating a statin or anticoagulant during 2005-2012. We calculated the cross-validated R from a series of hierarchical linear models to...

Full description

Saved in:
Bibliographic Details
Published in:Journal of comparative effectiveness research 2017-10, Vol.6 (7), p.613-625
Main Authors: Franklin, Jessica M, Donneyong, Macarius M, Desai, Rishi J, Markson, Leona, Girman, Cynthia J, McKay, Caroline, Patel, Mehul D, Mavros, Panagiotis, Schneeweiss, Sebastian
Format: Article
Language:English
Subjects:
adherence
Anticoagulants - therapeutic use
Atrial Fibrillation - drug therapy
Cohort Studies
Comparative Effectiveness Research
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Male
Medication Adherence
Middle Aged
mixed models
Pharmaceutical Services - statistics & numerical data
Retrospective Studies
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To assess heterogeneity in adherence to medications in two example comparative effectiveness research studies. We analyzed data from commercially insured patients initiating a statin or anticoagulant during 2005-2012. We calculated the cross-validated R from a series of hierarchical linear models to assess variation in 1-year adherence. There was less heterogeneity in adherence in the statin cohort compared with the anticoagulant cohort, where patient characteristics explained 7.2% of variation in adherence, and adding therapy and provider characteristics increased the proportion of variation explained to 8.0 and 8.5%, cumulatively. Random effects provided essentially no explanatory power, even in the statin cohort with large numbers of patients clustered within each pharmacy, prescriber and provider. The dependence of adherence on the healthcare system was stronger when the healthcare system influenced treatment choice and patient access to medication and when indications for treatment were strong.
ISSN:2042-6305
2042-6313
DOI:10.2217/cer-2016-0095